HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Correspondence: View responses Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in Neurology Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hayden, K. M. Search for Related Content PubMed PubMed Citation Articles by Hayden, K. M.

Does NSAID use modify cognitive trajectories in the elderly?

The Cache County Study

From the Department of Psychiatry and Behavioral Sciences (K.M.H., K.A.W.-B.), Duke University Medical Center, Durham, NC; Department of Mental Health (P.P.Z., C.A.S.), The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Khachaturian and Associates, Inc. (A.S.K.), Potomac, MD; Department of Neurology (M.F.), Johns Hopkins School of Medicine, Baltimore, MD; Sinai Hospital of Baltimore (M.F.), MD; Department of Family Consumer and Human Development (M.C.N.), Department of Psychology and Center for Epidemiologic Studies (M.C.N., J.T.T.), and Department of Mathematics and Statistics (C.C.), Utah State University, Logan; Department of Biometry and Bioinformatics and Center for the Study of Aging and Human Development (C.F.P.), Duke University, Durham, NC; Department of Psychiatry and Behavioral Sciences (C.G.L.), Johns Hopkins University School of Medicine, Baltimore, MD; VA Puget Sound Health Care System (J.C.S.B.), Seattle, WA; and Department of Psychiatry and Behavioral Sciences (J.C.S.B.), University of Washington School of Medicine, Seattle.

Address correspondence and reprint requests to Dr. Kathleen M. Hayden, DUMC, Joseph and Kathleen Bryan ADRC, 2200 West Main St., Suite A-200, Durham, NC 27705

Background: Epidemiologic studies have suggested that nonsteroidal anti-inflammatory drugs (NSAIDs) may be useful for the prevention of Alzheimer disease (AD). By contrast, clinical trials have not supported NSAID use to delay or treat AD. Few studies have evaluated cognitive trajectories of NSAID users over time.

Methods: Residents of Cache County, UT, aged 65 or older on January 1, 1995, were invited to participate in the study. At baseline, participants provided a detailed inventory of their medications and completed a revised Modified Mini-Mental State Examination (3MS). Participants (n = 3,383) who were cognitively normal at baseline were re-examined after 3 and 8 years. The association between NSAID use and 3MS scores over time was estimated using random effects modeling.

Results: Associations depended upon when NSAIDs were started and APOE genotype. In participants who started NSAID use prior to age 65, those with no APOE 4 alleles performed similarly to nonusers (a difference of 0.10 points per year; p = 0.19), while those with one or more 4 allele(s) showed more protection (0.40 points per year; p = 0.0005). Among participants who first used NSAIDs at or after age 65, those with one or more 4 alleles had higher baseline scores (0.95 points; p = 0.03) but did not show subsequent difference in change in score over time (0.06 points per year; p = 0.56). Those without an 4 allele who started NSAID use after age 65 showed greater decline than nonusers (–0.16 points per year; p = 0.02).

Conclusions: Nonsteroidal anti-inflammatory drug use may help to prevent cognitive decline in older adults if started in midlife rather than late life. This effect may be more notable in those who have one or more APOE 4 alleles.

khayden{at}duke.edu

Editorial, see page 235

Funded in part by NIA grants R01-AG11380 and T32-AG00029, and NIMH grant T32-MH14592.

Disclosure: The authors report no conflicts of interest.

Received October 25, 2006. Accepted in final form March 15, 2007.

Related articles in Neurology:

NSAIDs in the prevention of dementia: A Cache-22?

Jeremiah M. Scharf and Kirk R. Daffner
Neurology 2007 69: 235-236. [Full Text]  

This article has been cited by other articles:

				Z. Arvanitakis, F. Grodstein, J. L. Bienias, J. A. Schneider, R. S. Wilson, J. F. Kelly, D. A. Evans, and D. A. Bennett Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology Neurology, June 3, 2008; 70(23): 2219 - 2225. [Abstract] [Full Text] [PDF]

				D. F. Weaver and M. D. Carter DOES NSAID USE MODIFY COGNITIVE TRAJECTORIES IN THE ELDERLY? THE CACHE COUNTY STUDY Neurology, March 11, 2008; 70(11): 895 - 895. [Full Text] [PDF]

				P. B. Gorelick and J. V. Bowler Advances in Vascular Cognitive Impairment 2007 Stroke, February 1, 2008; 39(2): 279 - 282. [Full Text] [PDF]

				J. Rogers and M. N. Sabbagh Interactions of stroke, nonsteroidal anti-inflammatory drugs, and APOE status in dementia risk Neurology, January 1, 2008; 70(1): 5 - 6. [Full Text] [PDF]

				J. M. Scharf and K. R. Daffner NSAIDs in the prevention of dementia: A Cache-22? Neurology, July 17, 2007; 69(3): 235 - 236. [Full Text] [PDF]

Correspondence: